Biosciences
Our researchers in have a rich legacy of collaboration with government agencies and industry partners that improve health outcomes and well-being around the world. SRI Biosciences projects range from high-impact, early-stage research to drug co-development with pharmaceutical and biotech companies.
-
Nathan Collins talks about integrating AI with the SynFini™ Platform (Part 2)
Nathan Collins discusses how integrating AI with the SynFini automated chemistry platform is poised to shape the future of drug discovery and development. Learn more about SynFini at: https://www.sri.com/case-studies/synfini Nathan Collins is the Chief Strategy Officer of SRI Biosciences in Menlo Park, CA. In part two of this episode of The Dish TV they discuss…
-
If better sleep is part of your New Year’s resolution, check out this study from SRI researchers about the usefulness of a fitness watch for sleep tracking